Search results
BrainStorm Cell Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate...
Morningstar· 7 days agoCompany received written agreement from the U.S. FDA under a Special Protocol Assessment (SPA) on the design for a Phase 3b trial of NurOwn® Conference call planned for later this quarter to ...
Forbes Releases 2024 30 Under 30 Asia List
Forbes· 6 days ago2024 List Highlights 300 Outstanding Young Entrepreneurs and Trailblazers from Across the Asia-Pacific Region #ForbesU30Asia #ForbesUnder30